Your browser doesn't support javascript.
loading
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction.
Yamamoto, Kei; Ohsiro, Yusuke; Suzuki, Tetsuya; Suzuki, Michiyo; Miura, Sayaka; Nagashima, Maki; Iwamoto, Noriko; Takeuchi, Junko S; Kimura, Moto; Sugiura, Wataru; Nebuya, Satoru; Kurokawa, Masato; Ohmagari, Norio.
  • Yamamoto K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ohsiro Y; Clinical Laboratory, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Suzuki M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Miura S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nagashima M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Iwamoto N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Takeuchi JS; Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Kimura M; Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nebuya S; Sanyo Chemical Industries, Ltd., Higashiyama-ku, Kyoto, Japan.
  • Kurokawa M; Sanyo Chemical Industries, Ltd., Higashiyama-ku, Kyoto, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
PLoS One ; 18(3): e0279897, 2023.
Article en En | MEDLINE | ID: mdl-36996138

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article